Protalix Biotherapeutics Stock Technical Analysis
| PLX Stock | USD 2.38 0.01 0.42% |
As of the 31st of January, Protalix Biotherapeutics holds the Semi Deviation of 2.54, risk adjusted performance of 0.2243, and Coefficient Of Variation of 386.31. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protalix Biotherapeutics, as well as the relationship between them.
Protalix Biotherapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Protalix, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProtalixProtalix |
Protalix Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Protalix Biotherapeutics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Protalix Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Protalix Biotherapeutics Trend Analysis
Use this graph to draw trend lines for Protalix Biotherapeutics. You can use it to identify possible trend reversals for Protalix Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Protalix Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Protalix Biotherapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Protalix Biotherapeutics applied against its price change over selected period. The best fit line has a slop of 0.02 , which may imply that Protalix Biotherapeutics will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 14.78, which is the sum of squared deviations for the predicted Protalix Biotherapeutics price change compared to its average price change.About Protalix Biotherapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Protalix Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Protalix Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Protalix Biotherapeutics price pattern first instead of the macroeconomic environment surrounding Protalix Biotherapeutics. By analyzing Protalix Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Protalix Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Protalix Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Protalix Biotherapeutics January 31, 2025 Technical Indicators
Most technical analysis of Protalix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Protalix from various momentum indicators to cycle indicators. When you analyze Protalix charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2243 | |||
| Market Risk Adjusted Performance | (2.48) | |||
| Mean Deviation | 2.99 | |||
| Semi Deviation | 2.54 | |||
| Downside Deviation | 3.49 | |||
| Coefficient Of Variation | 386.31 | |||
| Standard Deviation | 4.36 | |||
| Variance | 19.01 | |||
| Information Ratio | 0.2359 | |||
| Jensen Alpha | 1.16 | |||
| Total Risk Alpha | 0.6493 | |||
| Sortino Ratio | 0.2949 | |||
| Treynor Ratio | (2.49) | |||
| Maximum Drawdown | 27.92 | |||
| Value At Risk | (4.92) | |||
| Potential Upside | 7.61 | |||
| Downside Variance | 12.17 | |||
| Semi Variance | 6.46 | |||
| Expected Short fall | (4.06) | |||
| Skewness | 1.3 | |||
| Kurtosis | 4.53 |
Additional Tools for Protalix Stock Analysis
When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.